PE Fund Investments
PAG consortium acquires controlling stake in Optimus Drugs
A Private Equity consortium led by Pacific Alliance Group (PAG) and including CX Partners and Samara Capital, is to acquire a controlling stake in Hyderabad-based pharmaceutical firm Optimus Drugs at a value of over INR 2,000 crore. Jayendra Shah acted as transaction advisor, N.A. Shah Advisory Services LLP acted as financial and tax advisors and Khaitan & Co. acted as legal advisors to the promoters in the transaction. For the PAG-led consortium, AZB & Partners acted as legal advisors and Citadel Management Consulting acted as financial advisor. Optimus Drugs is a vertically integrated manufacturer of pharmaceutical products including advanced intermediates, active pharmaceutical ingredients (APIs) and finished drugs. The company exports more than 100 drug products to 40 countries.
From the Venture Intelligence Private Company Financials Database: For Fy21, Optimus Drugs had reported an operational income of over INR 1,000-Cr. (Subscribers to the database can login to view the detailed financials.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
